4//SEC Filing
NEWLINK GENETICS CORP 4
Accession 0001126234-15-000034
CIK 0001126234operating
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:49 PM ET
Size
10.0 KB
Accession
0001126234-15-000034
Insider Transaction Report
Form 4
NEWLINK GENETICS CORP(NLNK)
Wiley Brian
VP of Business Development
Transactions
- Exercise/Conversion
Common Stock
2015-02-17$11.79/sh+10,000$117,900→ 24,855 total - Sale
Common Stock
2015-02-17$40.07/sh−10,000$400,700→ 14,855 total - Exercise/Conversion
Option to Purchase Common Stock
2015-02-17−10,000→ 119,000 totalExercise: $11.79Exp: 2023-01-13→ Common Stock (10,000 underlying)
Footnotes (5)
- [F1]Includes 4,275 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on January 2, 2016, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F2]Includes 7,400 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments beginning on January 2, 2016, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F3]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on 12/11/2014.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote to this Form 4.
- [F5]1/4th of the shares vest on January 14, 2014, which is one year after the vesting commencement date. 1/48th of the shares vest monthly thereafter over the next three years.
Documents
Issuer
NEWLINK GENETICS CORP
CIK 0001126234
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001126234
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:49 PM ET
- Size
- 10.0 KB